Atlas Trials

Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects

Clinical trial NCT02537405 · COMPLETED

Trial details

NCT number
NCT02537405
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Embolism, Atrial Fibrillation and Venous Thrombosis
Start date
2014-02-01
Primary completion
2014-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.